Differential modulation of transforming growth factor-β by betamethasone-17-valerate and isotretinoin: Corticosteroid decreases and isotretinoin increases the level of transforming growth factor-β in suction blister fluid

Skin Pharmacology and Applied Skin Physiology

Volumn 13, Issue 3-4, 2000, Pages 150-156

  Leivo, Tomi ^a,b,c,d,e   Arjomaa, P ^b   Oivula, J ^d   Vesterinen, M ^c   Kiistala, U ^b   Autio, P ^b   Oikarinen, A ^a  

^a UNIVERSITY OF OULU   (Finland)

^b CENTRAL MILITARY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NONE   (Finland)

Author keywords

Acne; Betamethasone; Glucocorticoid; Isotretinoin retinoid; Suction blister; Transforming growth factor

Indexed keywords

BETAMETHASONE VALERATE; ISOTRETINOIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; BLISTER; BLOOD LEVEL; CLINICAL TRIAL; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0034129394     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029920     Document Type: Article

References (22)

1. Bostrom MPG, Asnis P: Transforming growth factor beta in fracture repair. Clin Orthop 1998;355S: S124-S131.
2. Raghunath M, Unsold C, Kubitscheck U, Tuderman-Bruckner L, Peters R, Meuli M: The cutaneous microfibrillar apparatus contains latent transforming growth factor-β binding protein-1 (LTBP-1) and is a repository for latent TGF-β1. J Invest Dermatol 1998;111:559-564.
3. Roberts AB: Molecullar and cell biology of TGF-β. Miner Electrolyte Metab 1998;24:111-119.
4. Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC: Current use and future potential rule of retinoids in dermatology. Drugs 1997;53:358-388.
5. Leyden JJ: New understandings of the pathogenesis of acne. J Am Acad Dermatol 1995;32:15-25.
6. Taylor LE, Bennett GD, Finnell RH: Altered gene expression in murine branchial arches following in utero exposure to retinoic acid. J Craniofac Genet Dev Biol 1995;15: 13-25.
7. Griffiths WAD, Wilkinson JD: Topical therapy; in Champion RH, Burton JL, Burns DA, Breathnach SM (eds): Textbook of Dermatology. Oxford, Blackwell Science, 1998, vol 4, pp 3519-3564.
8. Almawi WY, Irani-Hakime N: The antiproliferative effect of glucocorticoids: Is it related to induction of TGF-β? Nephrol Dial Transplant 1998;13:2450-2452.
9. Batova A, Danielpour D, Pirisi L, Creek KE: Retinoic acid induces secretion of latent transforming growth factor β1 and β2 in normal and human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ 1992;3:763-772.
10. Kiistala U: Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968;50: 129-137.
11. Vermeer BJ, Reman FC, Gent CM: The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 1979;73:303-305.
12. Rossing N, Worm AM: Interstitial fluid: Exchange of macromolecules between plasma and skin interstitium. Clin Physiol 1981;1:275-284.
13. Herfst MJ, van Rees H: Suction blister fluid as a model for interstitial fluid in rats. Arch Dermatol Res 1978;263:325-334.
14. Bonifati C, Carducci M, Mussi A, Pittarello A, D'Agosto G, Fazio M, Ameglio F: The levels of transforming growth factor-β1 are increased in the serum of patients with psoriasis and correlate with disease severity. Eur J Dermatol 1996;6:486-490.
15. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RSH, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA, Sporn MB: Transforming growth factor-β1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1995;1:129-136.
16. Grainger DJ, Percival J, Chiano M, Spector TD: The role of serum TGF-β isoforms as potential markers of osteoporosis. Osteoporos Int 1999; 9:398-404.
17. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC: Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin. Nat Med 1995;1:932-937.
18. Cheifetz S, Weatherbee JA, Tsang ML-S, Anderson JK, Mole JE, Lucas R, Massague J: The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 1987;48:409-415.
19. Fisher GJ, Tavakkol A, Griffiths CEM, Elder JT, Zhang Q-Y, Finkel L, Danielpour D, Glick AB, Higley H, Ellingsworth L, Voorhees JJ: Differential modulation of transforming growth factor-β1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J Invest Dermatol 1992;98: 102-108.
20. DiPaola RS, Weiss RE, Cummings KB, Kong FM, Jirtle RL, Anscher M, Gallo J, Goodin S, Thompson S, Rasheed Z, Aisner J, Todd MB: Effect of 13-cis-retinoic acid and α-interferon on transforming growth factor β1 in patients with rising prostate-specific antigen. Clin Cancer Res 1997;3:1999-2004.
21. Kiistala U, Oikarinen A, Järvinen M, Ruokonen A: Alpha-thiolproteinase inhibitor, alpha 1-antitrypsin and serum proteins in suction blister fluid: Effect of local glucocorticosteroid treatment. Arch Dermatol Res 1986;278:497-499.
22. Haapasaari K-M, Risteli J, Oikarinen A: Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects. Br J Dermatol 1996;135: 65-69.